Medical News

RSS

CRISPR-based Cellgorithm technology ushers in a new era of cell programming

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of new research in Science Advances detailing the company's CRISPR-based Cellgorithm technology, which lays the groundwork for programmable control of gene activity in human stem cells and offers an alternative to the slow, variable manual processes researchers use today.

5 Dec 2025

Most Americans still back early hepatitis B vaccination despite policy debate

On December 5, 2025, the Trump administration's Advisory Committee on Immunization Practices (ACIP), whose members were handpicked by Health and Human Services (HHS) Secretary and vaccination critic Robert F. Kennedy Jr., is scheduled to determine whether it should recommend that the Centers for Disease Control and Prevention (CDC) change the recommendation in place since 1991 that newborns be vaccinated against hepatitis B.

5 Dec 2025

Genetic variant linked to higher heart failure risk in children with myocarditis

A genetic variant is likely putting some children suffering with myocarditis - inflammation of the heart muscle - at higher risk of developing heart failure, which can be fatal, according to a study published today in Circulation Heart Failure.

5 Dec 2025

Tenascin C as a key to restoring muscle regeneration in aging

As we age, the muscles we rely on for daily activities tend to become less reliable. With enough decline, even normal movements such as getting out of bed become risky.

5 Dec 2025

Restrictive state abortion laws may affect frontline care in obstetric emergencies

Although the United States does not guarantee health care as a right, federal law mandates that hospitals cannot deny anyone lifesaving emergency care.

5 Dec 2025

$New targeted alpha therapy shows promise for patients with radioiodine-refractory thyroid cancer$

New targeted alpha therapy shows promise for patients with radioiodine-refractory thyroid cancer

A new targeted alpha therapy is showing promise for patients whose thyroid cancer no longer responds to radioactive iodine, the standard beta-emitting treatment. In a first-in-human study, investigators found that a single dose of the alpha-emitting radionuclide 211At (astatine) was both well-tolerated and effective, achieving disease control without molecularly targeted drugs.

5 Dec 2025

New atomic structure reveals how NBCn1 transporter protein aids breast cancer cell survival

UCLA scientists have characterized the structure and function of a key survival protein in breast cancer cells that helps explain how these tumors resist environmental stress and thrive in acidic, low-oxygen environments that would normally be toxic to healthy cells.

5 Dec 2025

AI model could help radiologists identify brain abnormalities in MRI scans

A new AI model could help radiologists identify brain abnormalities in MRI scans for all conditions including stroke, multiple sclerosis and brain tumors.

5 Dec 2025

Researchers highlight five pathways through which microplastics can harm the brain

Microplastics could be fueling neurodegenerative diseases like Alzheimer's and Parkinson's, with a new study highlighting five ways microplastics can trigger inflammation and damage in the brain.

5 Dec 2025

Modern pollutants and ancient genetic variants could explain why some women develop endometriosis

A new study suggests that certain genetic differences, passed down from ancient human ancestors, and exposure to common present-day chemicals could explain why some women are more likely to develop endometriosis.

5 Dec 2025

Novel antibody suppresses primary tumor growth and spread of triple-negative breast cancer

Triple-negative breast cancer (TNBC) is one of the most aggressive and treatment-resistant forms of breast cancer. It grows quickly, spreads early and lacks the hormone receptors that make other breast cancers treatable with targeted therapies.

5 Dec 2025

New combination treatment helps people with recurring grade 3 astrocytoma, trial shows

Huntsman Cancer Institute at the University of Utah (the U) participated in a clinical trial that found that a new combination treatment plan helped people with recurring grade 3 astrocytoma, an aggressive form of brain cancer, live longer.

5 Dec 2025

Smoking fewer cigarettes does not eliminate cardiovascular disease risk

In a study funded by the National Heart, Lung, and Blood Institute, new research from Johns Hopkins Medicine adds to existing evidence that smoking fewer cigarettes does not eliminate cardiovascular disease risk, and quitting entirely is the most effective strategy for improving health.

5 Dec 2025

Study shines light on how P2X4 receptor can be inhibited

A study carried out by the University of Bonn and the University Hospital Bonn throws light on how an important receptor can be inhibited.

5 Dec 2025

Study shows how respiratory rhythm shapes memory processes

First and foremost, we breathe in order to absorb oxygen - but this vital rhythm could also have other functions. Over the past few years, a range of studies have shown that respiration influences neural processes, including the processing of stimuli and memory processes.

5 Dec 2025

Research examines oral health benefits of toothbrush choice and brushing duration

Real progress in oral health doesn't come from expensive gadgets, but from better daily habits. That is the conclusion of dentist- periodontist Tim Thomassen in his dissertation Oral Disease Prevention, which he will defend on 12 December at the University of Amsterdam.

5 Dec 2025

New study to explore how screen time affects babies and their families during first 1001 days of life

Professor James Wolffsohn and Dr. Amy Sheppard from Aston University School of Optometry are part of a new study which will explore how screen time affects babies and their families during the first 1001 days of life.

5 Dec 2025

First new fibromyalgia drug in 15 years, Tonmya (cyclobenzaprine HCl) gains FDA approval and hits pharmacy shelves

In a milestone moment for chronic pain management, Tonix Pharmaceuticals announced on August 15, 2025, that its novel sublingual therapy Tonmya has received approval from the U.S. Food and Drug Administration (FDA) - marking the first new drug for Fibromyalgia in more than 15 years.

From Hanson Wade Group - Non-Opioid Pain Therapeutics Summit 5 Dec 2025

Early reversal of unhealthy weight can protect the heart from higher childhood BMI

Overweight as a child is not necessarily a risk factor for heart attack later in life. If weight is normalized before adulthood, the heart seems unaffected by the higher childhood BMI, according to a study conducted at the University of Gothenburg.

5 Dec 2025

Health savings accounts, backed by GOP, cover fancy saunas but not insurance premiums

With the tax-free money in a health savings account, a person can pay for eyeglasses or medical exams, as well as a $1,700 baby bassinet or a $300 online parenting workshop.

5 Dec 2025

Medical News

CRISPR-based Cellgorithm technology ushers in a new era of cell programming

Most Americans still back early hepatitis B vaccination despite policy debate

Genetic variant linked to higher heart failure risk in children with myocarditis

Tenascin C as a key to restoring muscle regeneration in aging

Restrictive state abortion laws may affect frontline care in obstetric emergencies

New targeted alpha therapy shows promise for patients with radioiodine-refractory thyroid cancer

New atomic structure reveals how NBCn1 transporter protein aids breast cancer cell survival

AI model could help radiologists identify brain abnormalities in MRI scans

Researchers highlight five pathways through which microplastics can harm the brain

Modern pollutants and ancient genetic variants could explain why some women develop endometriosis

Novel antibody suppresses primary tumor growth and spread of triple-negative breast cancer

New combination treatment helps people with recurring grade 3 astrocytoma, trial shows

Smoking fewer cigarettes does not eliminate cardiovascular disease risk

Study shines light on how P2X4 receptor can be inhibited

Study shows how respiratory rhythm shapes memory processes

Research examines oral health benefits of toothbrush choice and brushing duration

New study to explore how screen time affects babies and their families during first 1001 days of life

First new fibromyalgia drug in 15 years, Tonmya (cyclobenzaprine HCl) gains FDA approval and hits pharmacy shelves

Early reversal of unhealthy weight can protect the heart from higher childhood BMI

Health savings accounts, backed by GOP, cover fancy saunas but not insurance premiums

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Extending the reach of Amperia™

Latest News